NASDAQ:SRDX

Surmodics News Headlines

$58.19
-0.96 (-1.62 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$57.68
Now: $58.19
$59.75
50-Day Range
$51.68
MA: $54.80
$59.15
52-Week Range
$33.45
Now: $58.19
$59.19
Volume24,341 shs
Average Volume53,708 shs
Market Capitalization$800.46 million
P/E Ratio727.38
Dividend YieldN/A
Beta1

Headlines

Surmodics (NASDAQ SRDX) News Headlines Today

SourceHeadline
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs - BenzingaThe Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs - Benzinga
benzinga.com - April 16 at 2:13 PM
Surmodics (NASDAQ:SRDX) Sets New 12-Month High at $58.85Surmodics (NASDAQ:SRDX) Sets New 12-Month High at $58.85
americanbankingnews.com - April 15 at 5:22 PM
Why Facebook (FB) is Poised to Beat Earnings Estimates Again - NasdaqWhy Facebook (FB) is Poised to Beat Earnings Estimates Again - Nasdaq
nasdaq.com - April 13 at 8:31 AM
Murphy Oil (MUR) to Gain on Cost Savings, High-Margin Assets - NasdaqMurphy Oil (MUR) to Gain on Cost Savings, High-Margin Assets - Nasdaq
nasdaq.com - April 12 at 2:06 PM
Neogen (NEOG) Hits New 52-Week High: Whats Driving It? - NasdaqNeogen (NEOG) Hits New 52-Week High: What's Driving It? - Nasdaq
nasdaq.com - April 12 at 2:06 PM
Heres Why You Should Hold NextGen (NXGN) in Your Portfolio - NasdaqHere's Why You Should Hold NextGen (NXGN) in Your Portfolio - Nasdaq
nasdaq.com - April 12 at 2:06 PM
Heres Why You Should Hold NextGen (NXGN) in Your PortfolioHere's Why You Should Hold NextGen (NXGN) in Your Portfolio
finance.yahoo.com - April 12 at 2:06 PM
Neogen (NEOG) Hits New 52-Week High: Whats Driving It?Neogen (NEOG) Hits New 52-Week High: What's Driving It?
finance.yahoo.com - April 12 at 2:06 PM
Merck KGaA Chooses PRA Healths (PRAH) Remote Monitoring Tool - NasdaqMerck KGaA Chooses PRA Health's (PRAH) Remote Monitoring Tool - Nasdaq
nasdaq.com - April 8 at 10:46 PM
PAHC or SRDX: Which Is the Better Value Stock Right Now? - NasdaqPAHC or SRDX: Which Is the Better Value Stock Right Now? - Nasdaq
nasdaq.com - April 7 at 4:39 PM
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award - BenzingaThe Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award - Benzinga
benzinga.com - April 7 at 11:38 AM
BDs (BDX) $65M Investment to Boost Supply-Chain Strength - NasdaqBD's (BDX) $65M Investment to Boost Supply-Chain Strength - Nasdaq
nasdaq.com - April 6 at 10:38 PM
Surmodics (NASDAQ:SRDX) Sets New 12-Month High at $58.48Surmodics (NASDAQ:SRDX) Sets New 12-Month High at $58.48
americanbankingnews.com - April 6 at 10:38 AM
Surmodics reports successful first patient uses of Sublime radial access platform devices - Seeking AlphaSurmodics reports successful first patient uses of Sublime radial access platform devices - Seeking Alpha
seekingalpha.com - April 3 at 9:57 AM
Charles W. Olson Sells 4,759 Shares of Surmodics, Inc. (NASDAQ:SRDX) StockCharles W. Olson Sells 4,759 Shares of Surmodics, Inc. (NASDAQ:SRDX) Stock
americanbankingnews.com - April 2 at 4:30 PM
Buy 3 MedTech Stocks That Are Outperforming S&P 500 in 2021 - NasdaqBuy 3 MedTech Stocks That Are Outperforming S&P 500 in 2021 - Nasdaq
nasdaq.com - April 1 at 12:44 PM
Surmodics Announces Successful First Patient Uses of Two Sublime™ Radial Access Platform Devices - Business WireSurmodics Announces Successful First Patient Uses of Two Sublime™ Radial Access Platform Devices - Business Wire
businesswire.com - April 1 at 12:44 PM
Buy 3 MedTech Stocks That Are Outperforming S&P 500 in 2021Buy 3 MedTech Stocks That Are Outperforming S&P 500 in 2021
finance.yahoo.com - April 1 at 12:44 PM
BD (BDX) Receives FDA EUA for Combination Rapid Antigen Test - NasdaqBD (BDX) Receives FDA EUA for Combination Rapid Antigen Test - Nasdaq
nasdaq.com - March 31 at 3:43 PM
Surmodics (NASDAQ:SRDX) Sets New 52-Week High at $56.62Surmodics (NASDAQ:SRDX) Sets New 52-Week High at $56.62
americanbankingnews.com - March 31 at 12:00 PM
PerkinElmers (PKI) Horizon Discovery Broadens Portfolio - NasdaqPerkinElmer's (PKI) Horizon Discovery Broadens Portfolio - Nasdaq
nasdaq.com - March 30 at 2:59 PM
Surmodics to Present at Sidoti & Company Virtual Investor Conference - Yahoo FinanceSurmodics to Present at Sidoti & Company Virtual Investor Conference - Yahoo Finance
finance.yahoo.com - March 17 at 5:36 PM
Surmodics to Present at Sidoti & Company Virtual Investor ConferenceSurmodics to Present at Sidoti & Company Virtual Investor Conference
finance.yahoo.com - March 17 at 5:36 PM
Why You Should Add Surmodics (SRDX) to Your Portfolio Now - Yahoo FinanceWhy You Should Add Surmodics (SRDX) to Your Portfolio Now - Yahoo Finance
finance.yahoo.com - March 17 at 7:35 AM
Why You Should Add Surmodics (SRDX) to Your Portfolio Now - NasdaqWhy You Should Add Surmodics (SRDX) to Your Portfolio Now - Nasdaq
nasdaq.com - March 16 at 3:25 PM
The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmons FDA Review, Alzheimers Data From Prothena - Yahoo FinanceThe Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena - Yahoo Finance
finance.yahoo.com - March 11 at 12:29 PM
The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytus Positive COVID-19 Data - BenzingaThe Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data - Benzinga
benzinga.com - March 9 at 8:55 AM
Surmodics Inc (SRDX) Q1 2021 Earnings Call TranscriptSurmodics Inc (SRDX) Q1 2021 Earnings Call Transcript
finance.yahoo.com - February 9 at 8:00 PM
Surmodics Reports First Quarter Fiscal 2021 ResultsSurmodics Reports First Quarter Fiscal 2021 Results
finance.yahoo.com - February 9 at 9:54 AM
SurModics (SRDX) Beats Q1 Earnings EstimatesSurModics (SRDX) Beats Q1 Earnings Estimates
finance.yahoo.com - February 9 at 9:54 AM
How Does Surmodics (NASDAQ:SRDX) CEO Pay Compare With Company Performance?How Does Surmodics' (NASDAQ:SRDX) CEO Pay Compare With Company Performance?
finance.yahoo.com - February 5 at 3:06 PM
Surmodics to Webcast First Quarter Fiscal 2021 Earnings Conference Call on February 9Surmodics to Webcast First Quarter Fiscal 2021 Earnings Conference Call on February 9
finance.yahoo.com - February 1 at 1:18 PM
12-Month Data from Surmodics’ TRANSCEND Trial Presented at LINC 2021 Event12-Month Data from Surmodics’ TRANSCEND Trial Presented at LINC 2021 Event
finance.yahoo.com - January 25 at 1:22 PM
Surmodics, Inc. (SRDX)Surmodics, Inc. (SRDX)
ca.finance.yahoo.com - January 17 at 6:27 PM
Surmodics Announces TRANSCEND Trial 12-Month Data to be Presented at LINC 2021 Virtual EventSurmodics Announces TRANSCEND Trial 12-Month Data to be Presented at LINC 2021 Virtual Event
finance.yahoo.com - January 12 at 12:12 PM
Is SRDX A Good Stock To Buy Now?Is SRDX A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 12:52 PM
Why Is SurModics (SRDX) Up 6.4% Since Last Earnings Report?Why Is SurModics (SRDX) Up 6.4% Since Last Earnings Report?
finance.yahoo.com - December 4 at 3:59 PM
Surmodics (SRDX) Reports Q4 Loss, Revenues Beat EstimatesSurmodics (SRDX) Reports Q4 Loss, Revenues Beat Estimates
finance.yahoo.com - November 5 at 1:36 PM
Surmodics EPS misses by $0.10, beats on revenueSurmodics EPS misses by $0.10, beats on revenue
seekingalpha.com - November 4 at 10:10 PM
Surmodics EPS misses by $0.10, beats on revenueSurmodics EPS misses by $0.10, beats on revenue
seekingalpha.com - November 4 at 10:10 PM
Recap: Surmodics Q4 EarningsRecap: Surmodics Q4 Earnings
finance.yahoo.com - November 4 at 10:10 PM
Recap: Surmodics Q4 EarningsRecap: Surmodics Q4 Earnings
finance.yahoo.com - November 4 at 10:10 PM
SurModics (SRDX) Reports Q4 Loss, Tops Revenue EstimatesSurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - November 4 at 10:10 PM
SurModics (SRDX) Reports Q4 Loss, Tops Revenue EstimatesSurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - November 4 at 10:10 PM
Surmodics Reports Fourth Quarter Fiscal 2020 ResultsSurmodics Reports Fourth Quarter Fiscal 2020 Results
finance.yahoo.com - November 4 at 5:09 PM
Surmodics to Webcast Fourth Quarter Fiscal 2020 Earnings Conference Call on November 4Surmodics to Webcast Fourth Quarter Fiscal 2020 Earnings Conference Call on November 4
finance.yahoo.com - October 27 at 1:42 PM
Earnings Preview: SurModics (SRDX) Q4 Earnings Expected to DeclineEarnings Preview: SurModics (SRDX) Q4 Earnings Expected to Decline
finance.yahoo.com - October 22 at 1:45 PM
NUVA or SRDX: Which Is the Better Value Stock Right Now?NUVA or SRDX: Which Is the Better Value Stock Right Now?
nasdaq.com - October 12 at 4:23 PM
SURMODICS INC. Registered Share (SU6.SG)SURMODICS INC. Registered Share (SU6.SG)
au.finance.yahoo.com - October 11 at 5:31 PM
Surmodics, Inc. (SU6.F)Surmodics, Inc. (SU6.F)
in.finance.yahoo.com - October 8 at 7:58 AM
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.